Delivery Order SPE2DB24D3013-SPE2DB25FFQWT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,267.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.24 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a single delivery order issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) valued at $1,381.44. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $3,829.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,646.19 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on September 17, 2025, with completion scheduled for September 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is...
- The Defense Logistics Agency awarded a $2,854.29 delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of April 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $2,675.76. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,804.17. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQWTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,207.24 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This non-competitive, firm fixed-price delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has been awarded this contract based on its established capacity to meet Defense Logistics Agency pharmaceutical supply requirements. The company serves military and veteran healthcare systems through its comprehensive pharmaceutical and medical supply portfolio, which includes brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This specific delivery order for amphetamine-based pharmaceutical products supports the medical supply needs of the Defense Health Agency and other government healthcare systems operating under the DLA Troop Support Medical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/24/25 |